West Virginia House Bill HB4213

West Virginia 2022 Regular Session

• Introduced: 1/18/22
• Refer: 1/18/22

Caption

Authorizing the Board of Osteopathic Medicine to promulgate rule relating to Practitioner Requirements for Controlled Substances Licensure and Accessing the West Virginia Controlled Substances Monitoring Program Database

Impact

The impact of HB 4213 is significant for the practice of osteopathic medicine in West Virginia. By formalizing the requirements surrounding licensure and the access to controlled substance databases, the bill seeks to promote accountability and responsible prescribing practices among practitioners. This modification is viewed as essential in combating issues related to substance misuse and ensuring that healthcare providers have the necessary oversight when handling controlled substances. Additionally, the establishment of clearer requirements can streamline licensure processes and improve public health outcomes.

Summary

House Bill 4213 is a legislative proposal that aims to authorize the Board of Osteopathic Medicine in West Virginia to promulgate a rule concerning the requirements for practitioners in relation to controlled substances licensure. The bill is focused primarily on enhancing the existing framework for the supervision and regulation of osteopathic practitioners, particularly with respect to their ability to access the West Virginia Controlled Substances Monitoring Program Database. The intent is to align practitioners' access with statutory and regulatory requirements to improve controlled substance management within the state.

Sentiment

The sentiment surrounding HB 4213 appears to be largely supportive among healthcare professionals and regulatory advocates who see the bill as a necessary measure to strengthen oversight and regulation in the face of ongoing substance abuse challenges. There are acknowledged concerns regarding possible bureaucratic burdens, but overall, the push for improved regulation is viewed positively. Stakeholders in the osteopathic community are generally in favor of the additional measures to maintain public trust and safety when prescribing controlled substances.

Contention

Notable points of contention may emerge around the implications of enforcing the proposed rules and the potential for increased regulatory scrutiny. Critics may argue that additional regulations could create barriers for practitioners or delay access to necessary medications for patients. However, proponents of the bill believe that these measures are crucial for ensuring ethical practices and protecting public health in the long run. The debate surrounding this legislation underscores the balance between regulatory enforcement and the practical needs of healthcare delivery.